Applied Genetic Technologies Stock Forecast, Price & News

Applied Genetic Technologies (NASDAQ:AGTC) Frequently Asked Questions

Is Applied Genetic Technologies a buy right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Applied Genetic Technologies in the last twelve months. There are currently 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Applied Genetic Technologies stock.
View analyst ratings for Applied Genetic Technologies or view top-rated stocks.

How has Applied Genetic Technologies' stock price been impacted by COVID-19?

Applied Genetic Technologies' stock was trading at $3.84 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, AGTC shares have decreased by 38.0% and is now trading at $2.38.
View which stocks have been most impacted by COVID-19.

Are investors shorting Applied Genetic Technologies?

Applied Genetic Technologies saw a decrease in short interest during the month of November. As of November 15th, there was short interest totaling 2,250,000 shares, a decrease of 27.9% from the October 31st total of 3,120,000 shares. Based on an average daily trading volume, of 572,100 shares, the days-to-cover ratio is currently 3.9 days. Approximately 5.8% of the company's stock are sold short.
View Applied Genetic Technologies' Short Interest.

When is Applied Genetic Technologies' next earnings date?

Applied Genetic Technologies is scheduled to release its next quarterly earnings announcement on Thursday, February 10th 2022.
View our earnings forecast for Applied Genetic Technologies.

How were Applied Genetic Technologies' earnings last quarter?

Applied Genetic Technologies Co. (NASDAQ:AGTC) released its quarterly earnings data on Tuesday, November, 9th. The biotechnology company reported ($0.40) earnings per share for the quarter, missing the consensus estimate of ($0.35) by $0.05. During the same quarter last year, the company earned ($0.60) EPS.
View Applied Genetic Technologies' earnings history.

What price target have analysts set for AGTC?

6 brokers have issued twelve-month target prices for Applied Genetic Technologies' shares. Their forecasts range from $11.00 to $35.00. On average, they anticipate Applied Genetic Technologies' share price to reach $21.00 in the next twelve months. This suggests a possible upside of 782.4% from the stock's current price.
View analysts' price targets for Applied Genetic Technologies or view top-rated stocks among Wall Street analysts.

Who are Applied Genetic Technologies' key executives?

Applied Genetic Technologies' management team includes the following people:

• Susan B. Washer, President, Chief Executive Officer & Director
• Jonathan I. Lieber, Chief Financial Officer
• Stephen W. Potter, Chief Business Officer & Vice President
• Matthew Feinsod, Executive VP-Global Strategy & Development
• Sarah C. DiSalvatore, Vice President-Clinical Operations

Who are some of Applied Genetic Technologies' key competitors?

Some companies that are related to Applied Genetic Technologies include Ambrx Biopharma (AMAM), Cellectis (CLLS), Passage Bio (PASG), Innate Pharma (IPHA), Innate Pharma (IPHYF), Molecular Partners (MOLN), Cortexyme (CRTX), SQZ Biotechnologies (SQZ), Lineage Cell Therapeutics (LCTX), Acumen Pharmaceuticals (ABOS), DBV Technologies (DBVT), Cabaletta Bio (CABA), Jasper Therapeutics (JSPR), Opthea (OPT) and Compugen (CGEN).
View all of AGTC's competitors.

What other stocks do shareholders of Applied Genetic Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Applied Genetic Technologies investors own include Sorrento Therapeutics (SRNE), SCYNEXIS (SCYX), Micron Technology (MU), VBI Vaccines (VBIV), Amarin (AMRN), Aldeyra Therapeutics (ALDX), Allena Pharmaceuticals (ALNA), Anavex Life Sciences (AVXL), Galmed Pharmaceuticals (GLMD) and Genocea Biosciences (GNCA).

What is Applied Genetic Technologies' stock symbol?

Applied Genetic Technologies trades on the NASDAQ under the ticker symbol "AGTC."

Who are Applied Genetic Technologies' major shareholders?

Applied Genetic Technologies' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Millennium Management LLC (2.84%), Geode Capital Management LLC (1.40%), GSA Capital Partners LLP (1.36%), Dimensional Fund Advisors LP (1.31%), Assenagon Asset Management S.A. (1.14%) and Two Sigma Advisers LP (0.76%).
View institutional ownership trends for Applied Genetic Technologies.

Which major investors are selling Applied Genetic Technologies stock?

AGTC stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Dimensional Fund Advisors LP, Squarepoint Ops LLC, Colony Group LLC, and Citadel Advisors LLC.
View insider buying and selling activity for Applied Genetic Technologies or view top insider-selling stocks.

Which major investors are buying Applied Genetic Technologies stock?

AGTC stock was bought by a variety of institutional investors in the last quarter, including GSA Capital Partners LLP, Two Sigma Advisers LP, Geode Capital Management LLC, Morgan Stanley, Goldman Sachs Group Inc., Two Sigma Investments LP, Assenagon Asset Management S.A., and Marshall Wace LLP.
View insider buying and selling activity for Applied Genetic Technologies or or view top insider-buying stocks.

How do I buy shares of Applied Genetic Technologies?

Shares of AGTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Applied Genetic Technologies' stock price today?

One share of AGTC stock can currently be purchased for approximately $2.38.

How much money does Applied Genetic Technologies make?

Applied Genetic Technologies has a market capitalization of $102.02 million and generates $500 thousand in revenue each year. The biotechnology company earns $-57.83 million in net income (profit) each year or ($1.68) on an earnings per share basis.

How many employees does Applied Genetic Technologies have?

Applied Genetic Technologies employs 83 workers across the globe.

What is Applied Genetic Technologies' official website?

The official website for Applied Genetic Technologies is www.agtc.com.

Where are Applied Genetic Technologies' headquarters?

Applied Genetic Technologies is headquartered at 14193 NW 119TH TERRACE SUITE 10, ALACHUA FL, 32615.

How can I contact Applied Genetic Technologies?

Applied Genetic Technologies' mailing address is 14193 NW 119TH TERRACE SUITE 10, ALACHUA FL, 32615. The biotechnology company can be reached via phone at (386) 462-2204 or via email at [email protected].